Create Free Account

By creating account you will get access to hot stocks & personalised emails

Alcidion Group Ltd

Healthcare AU ALC

0.052AUD
-0.002(3.70%)

Last update at 2024-05-01T06:10:00Z

Day Range

0.050.06
LowHigh

52 Week Range

0.040.13
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -4.74000M -3.90800M -0.93400M -4.01816M -0.10993M
Minority interest - - - - -
Net income -3.61700M -4.41200M -2.24400M -3.07660M -0.08417M
Selling general administrative 0.98M 1.10M 0.94M 0.90M 2.65M
Selling and marketing expenses 0.84M 0.58M 0.57M 0.56M 0.64M
Gross profit 1.25M 3.29M 3.52M 0.40M 5.91M
Reconciled depreciation 3.19M 2.26M 0.46M 0.25M 0.07M
Ebit -4.72600M -1.72800M -0.17400M -2.31801M -0.12548M
Ebitda -1.53900M 0.53M 0.28M -2.07064M -0.05959M
Depreciation and amortization 3.19M 2.26M 0.46M 0.25M 0.07M
Non operating income net other - - - - -
Operating income -4.72600M -1.72800M -0.17400M -2.31801M -0.12548M
Other operating expenses 45.13M 36.08M 26.06M 20.87M 16.99M
Interest expense 0.12M 0.07M 0.00300M 0.07M 0.02M
Tax provision -1.12300M 0.50M 1.31M -0.94156M -0.02576M
Interest income 0.11M 0.02M 0.01M 0.07M 0.02M
Net interest income -0.01400M -0.04400M 0.00900M 0.07M 0.02M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -1.12300M 0.50M 1.31M -0.94156M 0.03M
Total revenue 40.40M 34.35M 25.88M 18.55M 16.86M
Total operating expenses 5.98M 5.02M 3.69M 2.72M 6.04M
Cost of revenue 39.15M 31.06M 22.36M 18.15M 10.95M
Total other income expense net -0.01400M -2.18000M -0.76000M -1.70015M 0.02M
Discontinued operations - - - - -
Net income from continuing ops -3.61700M -4.41200M -2.24400M -3.07660M -0.08417M
Net income applicable to common shares -3.61700M -4.41200M -2.24400M -3.07660M -0.08417M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 120.68M 128.35M 58.38M 39.43M 24.86M
Intangible assets 29.07M 31.06M 2.03M 2.03M 17.45M
Earning assets - - - - -
Other current assets 1.60M 1.67M 1.21M 0.44M 0.28M
Total liab 30.52M 34.40M 13.16M 9.70M 11.61M
Total stockholder equity 90.17M 93.95M 45.22M 29.74M 13.24M
Deferred long term liab - - - - -
Other current liab 6.84M 9.22M 4.96M 3.51M 8.27M
Common stock 110.51M 110.51M 58.57M 41.07M 20.79M
Capital stock 110.51M 110.51M 58.57M 41.07M 20.79M
Retained earnings -21.60300M -17.98600M -13.57400M -11.32975M -8.22860M
Other liab 7.78M 8.14M 0.15M 0.15M 0.12M
Good will 67.76M 67.76M 25.46M 15.37M 15.39M
Other assets - - 0.00000M 1.26M 0.38M
Cash 14.64M 17.34M 25.03M 15.95M 3.17M
Cash and equivalents - - - - -
Total current liabilities 21.27M 24.39M 13.00M 9.41M 11.50M
Current deferred revenue 11.61M 12.91M 7.11M 4.73M 3.77M
Net debt -12.48600M -14.85500M -24.84600M -15.63211M -3.17184M
Short term debt 0.69M 0.62M 0.16M 0.18M -2.24408M
Short long term debt - - - - -
Short long term debt total 2.15M 2.48M 0.18M 0.32M -
Other stockholder equity 0.32M 1.43M 0.23M 0.62M 1.08M
Property plant equipment 2.87M 3.27M 0.55M 0.55M 0.16M
Total current assets 20.98M 26.26M 30.35M 20.23M 6.87M
Long term investments - - - - -
Net tangible assets -6.66800M -4.86900M 17.73M 12.34M -4.20789M
Short term investments - - - - -
Net receivables 4.74M 7.25M 4.11M 3.83M 3.42M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 2.13M 1.65M 0.77M 0.99M 1.70M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.26M 1.43M 0.23M -0.61645M 0.68M
Additional paid in capital - - - - -
Common stock total equity - - - 41.07M 20.79M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - -0.00200M - - 17.99M
Deferred long term asset charges - - - - -
Non current assets total 99.71M 102.09M 28.04M 19.21M 17.99M
Capital lease obligations 2.15M 2.48M 0.18M 0.32M -
Long term debt total 1.46M 1.87M 0.02M 0.14M 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -3.14100M -59.74300M -9.84300M -0.36204M -1.74081M
Change to liabilities -1.71200M 4.27M 2.92M -0.47829M 0.77M
Total cashflows from investing activities -3.14100M -59.74300M -9.84300M -0.36204M -1.74081M
Net borrowings -0.61600M -0.60900M -0.27000M -0.20683M 0.03M
Total cash from financing activities -0.61600M 51.33M 17.23M 15.16M 0.03M
Change to operating activities 0.54M -0.52800M -0.85500M 1.73M 3.13M
Net income -3.61700M -4.41200M -2.24400M -3.07660M -0.08417M
Change in cash -2.69800M -7.68800M 9.08M 12.78M 0.28M
Begin period cash flow 17.34M 25.03M 15.95M 3.17M 2.89M
End period cash flow 14.64M 17.34M 25.03M 15.95M 3.17M
Total cash from operating activities 0.17M -2.15600M 1.54M -2.01718M 1.99M
Issuance of capital stock - 51.94M 17.50M 15.36M -
Depreciation 1.81M 2.26M 0.46M 0.25M 0.07M
Other cashflows from investing activities -2.68700M -59.43200M -9.53000M -0.23822M -1.47603M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 2.52M -1.30200M 1.03M -0.41046M -1.89373M
Sale purchase of stock 0.00000M 51.94M 17.50M 15.36M -
Other cashflows from financing activities -0.61600M -0.60900M -0.27000M -0.17547M 0.09M
Change to netincome -0.36800M 0.33M 0.23M -0.00121M -0.00121M
Capital expenditures 0.45M 0.31M 0.31M 0.12M 0.26M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.11M 0.02M 0.01M 0.07M 0.02M
Stock based compensation - - - - -
Other non cash items - 2.16M 1.79M 2.83M 0.02M
Free cash flow -0.28500M -2.46700M 1.23M -0.12382M -0.26478M

Fundamentals

  • Previous Close 0.05
  • Market Cap73.84M
  • Volume533515
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.15400M
  • Revenue TTM40.48M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 34.77M
  • Diluted EPS TTM-

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ALC
Alcidion Group Ltd		 -0.002 3.70% 0.05 - 43.29 1.49 0.66 1.35 -17.2315
PME
Pro Medicus Ltd		 -2.16 1.94% 109.25 166.64 113.64 78.98 70.50 78.09 106.71
VHT
Volpara Health Technologies Ltd		 -0.005 0.44% 1.14 - - 7.65 6.53 7.78 -60.9831
CGS
CogState Ltd		 -0.005 0.36% 1.40 27.90 32.79 5.22 3.67 4.24 22.21
ONE
Oneview Healthcare PLC		 -0.02 6.78% 0.28 - - 26.22 16.80 25.10 -29.9289

Reports Covered

Stock Research & News

View All

Profile

Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management to address the requirements of clinical and non-clinical users; Patientrack, a real-time patient monitoring and risk screening solution; Silverlink, a patient administration system; and ExtraMed, a clinical and patient flow management software. It also provides product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.

Alcidion Group Ltd

9 Yarra Street, South Yarra, VIC, Australia, 3141

Key Executives

Name Title Year Born
Ms. Kate Quirke MD, CEO & Exec. Director NA
Mr. Matthew Gepp Chief Financial Officer NA
Mr. Colin Bruce MacKinnon Chief Operating Officer NA
Mr. Vivek Krishnan Chief Technology Officer NA
Kerstin Wahlqvist Investor Relations Mang. NA
Ms. Maria Hunter Group Gen. Counsel NA
Ms. Tracey Harvey HR Mang. NA
Ms. Lynette Ousby UK Managing Director NA
Ms. Amanda James Chief People Officer NA
Ms. Julia Stevens Chief of Staff NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.